Utah Medical Products Inc Enjoys Upgrade to 86% Rating

Utah Medical Products Inc sees its rating rise from 71% to 86%, reflecting strong fundamentals. Investors may find this upgrade indicative of positive underlying performance, potentially impacting stock prices favorably.

Date: 12-03-2025

AI Rating: 6

Overview of Upgrade: The report highlights that Utah Medical Products Inc (UTMD) has received a rating upgrade from 71% to 86% based on Benjamin Graham’s deep value methodology. This change suggests that the firm’s fundamentals are improving, which may attract investor interest.

Earnings Per Share (EPS): The report notes a 'PASS' for the long-term EPS growth. While exact figures are not provided, a 'PASS' indicates that EPS growth is on target with expectations, which is typically seen as a stabilizing factor for investors.

Sales: However, it is crucial to point out that the report indicates a 'FAIL' for sales. This could raise concerns regarding the company’s revenue performance, leading investors to approach the stock with caution despite other positive metrics.

Other Financial Metrics: The report confirms passes in several other important areas—current ratio, long-term debt in relation to net current assets, P/E ratio, and price/book ratio. These passes suggest that the company is managing its liabilities well, is valued favorably compared to earnings, and may provide a reasonable investment opportunity for value investors.

Conclusion: Given the rating increase and the positive marks in crucial aspects, there may be a bullish sentiment around UTMD stock. However, investors should weigh the failed sales metric alongside other positives to form a comprehensive view before making investment decisions.

Stocks: UTMD